Gadeta

Gadeta is a cell therapy company dedicated to developing innovative therapies based on g/d T cell receptors for targeting solid tumors. Gadeta's platform focuses on discovering and developing novel g/d T cell receptors (TCR) that can specifically identify new cancer-specific surface targets. It can eliminate cancer cells while sparing healthy tissue. The g/d TCR is an immune receptor expressed by a special type of immune cell, playing a crucial role in patrolling the body to detect any signs of cancer.